Zobrazeno 1 - 3
of 3
pro vyhledávání: '"J M, Minchenko"'
Autor:
I V, Dmytrenko, V G, Fedorenko, T Y, Shlyakhtychenko, V V, Sholoyko, T F, Lyubarets, T V, Malinkina, O O, Dmytrenko, V V, Balan, S M, Kravchenko, Z V, Martina, A O, Tovstogan, J M, Minchenko, I S, Dyagil
Publikováno v:
Problemy radiatsiinoi medytsyny ta radiobiolohii. 20
Assess the influence of e13a2 and e14a2 transcripts of BCR/ABL1 gene on the efficiency of imatinib ther apy in patients with chronic myeloid leukemia.We examined 508 patients with the chronic phase of chronic myeloid leukemia without radi ation in an
Autor:
I V, Dmytrenko, V G, Fedorenko, T Y, Shlyakhtychenko, V V, Sholoyko, T F, Lyubarets, T V, Malinkina, O O, Dmytrenko, V V, Balan, S M, Kravchenko, Z V, Martina, A O, Tovstogan, J M, Minchenko, I S, Dyagil
Publikováno v:
Problemy radiatsiinoi medytsyny ta radiobiolohii. 19
Objective. To study the efficiency of tyrosine kinase inhibitors (TKI) therapy in patients with chronic myeloid leukemia (CML) exposed to ionizing radiation due to the Chornobyl NPP accident, based on the data of cytogenetic and molecular monitoring.
Autor:
J M, Minchenko, I S, Dyagil, O O, Dmytrenko, I V, Dmytrenko, T Y, Shlaykhtychenko, T I, Gavrylenko, D O, Biliy, V I, Khomenko, V G, Bebeshko
Publikováno v:
Problemy radiatsiinoi medytsyny ta radiobiolohii. (18)
The objective was to study the immunogenetic component contribution to the formation of post-radiation effects in the long-term period after radiation exposure at the level of the human immune response as a prognostic criterion for risk assessment of